AbCellera Biologics (ABCL) SEC Filings & 10K Form

$3.78
0.00 (0.00%)
(As of 05/1/2024 ET)

Recent AbCellera Biologics SEC Filings

DateFilerForm TypeView
04/29/2024
3:47 PM
AbCellera Biologics (Filer)
Form ARS
04/29/2024
3:39 PM
AbCellera Biologics (Filer)
Form DEFA14A
02/27/2024
1:12 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:49 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
3:49 PM
AbCellera Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/20/2024
3:36 PM
AbCellera Biologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
3:27 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
10:47 AM
AbCellera Biologics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
01/16/2024
5:14 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
5:18 PM
AbCellera Biologics (Issuer)
Booth Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
5:21 PM
AbCellera Biologics (Issuer)
Stimart Tryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
5:23 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
5:08 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
4:28 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
2:29 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
3:13 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
7:03 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
11:26 AM
AbCellera Biologics (Issuer)
Hayden Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:38 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
11:22 AM
AbCellera Biologics (Issuer)
Hayden Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:33 PM
AbCellera Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
3:15 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
12:14 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
1:50 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
1:53 PM
AbCellera Biologics (Issuer)
Booth Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
1:36 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
2:02 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ABCL) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners